Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 Sanofi-Aventis Canada Inc. (3)
Patent
01 1329203 (3)
Product
01 Dolasetron Mesylate (3)
Dosage
01 Injection (1)
02 Tablet (2)
Exp Date
01 2011-05-03 (3)